Chemed Co. (NYSE:CHE) Stock Position Raised by Vanguard Group Inc. (2024)

Posted by MarketBeat News on Jun 21st, 2024

Vanguard Group Inc. lifted its stake in shares of Chemed Co. (NYSE:CHE – Free Report) by 0.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,699,648 shares of the company’s stock after acquiring an additional 1,859 shares during the quarter. Vanguard Group Inc. owned about 0.11% of Chemed worth $993,869,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. GAMMA Investing LLC bought a new stake in shares of Chemed during the 4th quarter worth $37,000. Principal Securities Inc. acquired a new stake in shares of Chemed in the fourth quarter worth $51,000. SRS Capital Advisors Inc. boosted its position in shares of Chemed by 110.6% in the fourth quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock worth $58,000 after buying an additional 52 shares during the period. Covestor Ltd boosted its position in shares of Chemed by 27.4% in the third quarter. Covestor Ltd now owns 144 shares of the company’s stock worth $75,000 after buying an additional 31 shares during the period. Finally, Larson Financial Group LLC boosted its position in shares of Chemed by 86.9% in the fourth quarter. Larson Financial Group LLC now owns 157 shares of the company’s stock worth $92,000 after buying an additional 73 shares during the period. 95.85% of the stock is owned by institutional investors.

Insider Buying and Selling at Chemed

In other Chemed news, EVP Spencer S. Lee sold 2,000 shares of the business’s stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the completion of the sale, the executive vice president now owns 20,760 shares of the company’s stock, valued at $13,320,654. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other Chemed news, EVP Spencer S. Lee sold 2,000 shares of the business’s stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the completion of the sale, the executive vice president now owns 20,760 shares of the company’s stock, valued at $13,320,654. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Kevin J. Mcnamara sold 1,500 shares of the business’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $544.17, for a total value of $816,255.00. Following the completion of the sale, the chief executive officer now directly owns 107,049 shares of the company’s stock, valued at approximately $58,252,854.33. The disclosure for this sale can be found here. Insiders have sold a total of 7,784 shares of company stock worth $4,523,353 over the last three months. Corporate insiders own 3.32% of the company’s stock.

Chemed Trading Up 0.2 %

Want More Great Investing Ideas?

CHE opened at $533.44 on Friday. The stock has a market cap of $8.08 billion, a price-to-earnings ratio of 28.71, a PEG ratio of 2.19 and a beta of 0.46. Chemed Co. has a 1 year low of $492.84 and a 1 year high of $654.62. The stock has a fifty day moving average price of $565.21 and a 200 day moving average price of $590.33.

Chemed (NYSE:CHE – Get Free Report) last released its quarterly earnings data on Wednesday, April 24th. The company reported $4.68 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). The firm had revenue of $589.23 million for the quarter, compared to analyst estimates of $587.18 million. Chemed had a net margin of 12.36% and a return on equity of 30.52%. As a group, sell-side analysts forecast that Chemed Co. will post 21.54 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 18th. Investors of record on Thursday, May 30th were given a dividend of $0.40 per share. The ex-dividend date was Thursday, May 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.30%. Chemed’s payout ratio is 8.61%.

Wall Street Analyst Weigh In

Several analysts have recently commented on CHE shares. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Oppenheimer raised their target price on Chemed from $625.00 to $650.00 and gave the stock an “outperform” rating in a research report on Thursday, February 29th. Finally, Royal Bank of Canada decreased their target price on Chemed from $712.00 to $697.00 and set an “outperform” rating for the company in a research report on Tuesday, May 21st.

Read Our Latest Stock Report on Chemed

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.